Skip to content

3’-(5’-Deoxy-α-D-ribofuranoyl) Capecitabine

3’-(5’-Deoxy-α-D-ribofuranoyl) Capecitabine

Product Description
CAT No.
ALN-C003015
CAS No.
1262133-68-5
Mol. F.
C20H30FN3O9
Mol. Wt.
475.5
Stock
Please Inquire
RFQ
Chemical Name : Cytidine, 5′-​deoxy-​3′-​O-​(5-​deoxy-​α-​D-​ribofuranosyl)​-​5-​fluoro-​N-​[(pentyloxy)​carbonyl]​-; 5′-Deoxy-3′-O-(5-deoxy-α-D-ribofuranosyl)-5-fluoro-N-[(pentyloxy)carbonyl]cytidine;
Smiles : O[C@H]1[C@H](N(C=C(F)C(NC(OCCCCC)=O)=N2)C2=O)O[C@H](C)[C@H]1O[C@](O[C@H](C)[C@H]3O)([H])[C@@H]3O
Inchi : InChI=1S/C9H16N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h4-8,12-15H,1-3H2,(H,10,16)/t4-,5?,6-,7-,8-/m1/s1

Design of experiments (DoE) - based enhanced quality by design approach to hydrolytic degradation kinetic study of capecitabine by eco-friendly stability indicating UV-visible spectrophotometry

By Prajapati, Pintu; Patel, Radhika; Patel, Dilan; Shah, ShaileshnFrom American Journal of PharmTech Research (2020), 10(6), 115-133

Validated stability indicating HPLC method for estimation of capecitabine

By Lalitha, K. V.; Raveendra Reddy, J.; Devanna, N. – From International Journal of Pharmaceutical Sciences and Research (2020), 11(11), 5651-5658

RP-HPLC method development and validation for the simultaneous estimation of Irinotecan hydrochloride and Capecitabine in Active Pharmaceutical Ingredients (APIs)

By Vijaya Jyothi, M.; Bhargav, E.; Keerthana, B.; Varalakshmi, Devi K. – From International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2018), 9(1), 63-67

Request For Quotation

Related Products